Longwall Venture Partners | Longwall Ventures Fund 4
◆ Fund Size
$102.3M
◆ Check Size
◆ Location
United Kingdom
◆ Portfolio
21 companies
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Supporting UK-based start-up and early-stage deeptech companies across science and engineering sectors, with focus on commercialising scientific research and breakthrough technologies
◆ About Longwall Venture Partners
Longwall Venture Partners is an Oxford-based UK venture capital firm focused on early-stage deeptech, healthcare, life science, science, and engineering companies.[1][2][3] It appears to invest in seed and Series A rounds, with a lead-and-follow approach and first tickets typically around £500k-£1.5m.[1]
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| David Denny | Managing Partner | Managing Partner | |
| Helen Viner FCA | Financial Controller | Financial Controller | |
| Jane Burgoyne | Partner and Chief Financial Officer | — | |
| Jane Burgoyne FCA | Managing Partner | Managing Partner | |
| Matthew Frohn | Managing Partner | Managing Partner | |
| Michael Penington | (1958-2024) | — | |
| Rebecca Todd | Partner | Partner |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Longwall Ventures Fund 4 invest in?
Longwall Ventures Fund 4 invests in Clean Energy, Defense Tech, Biotech, Advanced Materials and Manufacturing Tech at the seed and series-a stages.
Which geographies does Longwall Ventures Fund 4 focus on?
Longwall Ventures Fund 4 focuses on United Kingdom, and is headquartered in United Kingdom.
What is Longwall Ventures Fund 4's typical check size?
Longwall Ventures Fund 4 typically writes checks of $0.6M to $1.9M.